Delgocitinib

Overview

Delgocitinib is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL4297507).

Patent & exclusivity (US)

Per the FDA Orange Book (1 approved US product), the latest listed US patent on Delgocitinib expires 19 Sept 2031 and exclusivity 23 Jul 2030. Generic API sourcing typically opens up once these lapse.

Chemical identity

IUPAC name

3-[(3S,4R)-3-methyl-7-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1,7-diazaspiro[3.4]octan-1-yl]-3-oxopropanenitrile

Canonical SMILES

C[C@H]1CN([C@]12CCN(C2)C3=NC=NC4=C3C=CN4)C(=O)CC#N

InChIKey

LOWWYYZBZNSPDT-ZBEGNZNMSA-N